Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Syeda Arshiya, Farheen"'
Publikováno v:
Drugs in Context, Vol 11, Pp 1-9 (2022)
Prazosin, a centrally acting α1 adrenoceptor antagonist, has been included in two published algorithms amongst the list of medications that may be used in the management of behavioural and psychological symptoms of dementia (BPSD). However, a review
Externí odkaz:
https://doaj.org/article/c748bc090c6f436489529d85b78dccf8
Publikováno v:
Current Psychiatry. 20
Several agents may be useful for treating mild to moderate withdrawal symptoms.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e98e3699aa9d8f1e32a04e00aa9e9649
https://doi.org/10.12788/cp.0094
https://doi.org/10.12788/cp.0094
Autor:
Gargi Bhattacharya, Rajesh R. Tampi, Romika Dhar, Aarti Gupta, Palak Patadia, Syeda Arshiya Farheen, Melissa Funaro
Publikováno v:
International psychogeriatrics. 33(2)
Introduction Depression is the second most prevalent mental health disorder among older adults after anxiety disorders. It effects 7% of the general older population globally 5.6% of US older adults. Suicide rates also increase between ages of 60-90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8dd5d65c7d15b536d1e98e73b59e595
https://pubmed.ncbi.nlm.nih.gov/33750502
https://pubmed.ncbi.nlm.nih.gov/33750502
Publikováno v:
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 30(4)
Cariprazine was approved for treating schizophrenia and bipolar disorder, and currently is being evaluated for treating depression in clinical trials in the United States. We systematically reviewed the literature on the efficacy and safety of caripr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9dc5696b5db61c71eedb1fd1ddb43eac
https://pubmed.ncbi.nlm.nih.gov/30372510
https://pubmed.ncbi.nlm.nih.gov/30372510
Autor:
Aarti, Chhatlani, Syeda Arshiya, Farheen, Geetha, Manikkara, Madhuri Jakkam, Setty, Elizabeth, DeOreo, Rajesh R, Tampi
Publikováno v:
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 30(4)
This systematic review evaluates current literature on anticonvulsants to treat alcohol withdrawal symptoms (AWS).We performed a literature search of PubMed, MEDLINE, PsycINFO, EMBASE, and Cochrane collaboration databases through September 30, 2016.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9411fff4a6a16bb0bcf4cbc9c67503d8
https://pubmed.ncbi.nlm.nih.gov/30372509
https://pubmed.ncbi.nlm.nih.gov/30372509
Publikováno v:
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 30(3)
This systematic review identified published studies that evaluated the use of ondansetron in individuals with psychosis associated with dementia.A literature search was conducted of PubMed, MEDLINE, EMBASE, PsycINFO, and Cochrane Collaboration databa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e9c607f16901da38e490afd570be2fd0
https://pubmed.ncbi.nlm.nih.gov/30028894
https://pubmed.ncbi.nlm.nih.gov/30028894
Autor:
Rizwan Ahmed, Satneet Singh, Syeda Arshiya Farheen, Archana Rao Adikey, Venkatesh Sreeram, Pooja Shah, Mariyah Hussain, Manpreet Gill, Sumayya Ayaz, Saeed Ahmed
Publikováno v:
Clinical Depression.
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopamine in the substantia nigra. It is predominantly a motor disorder but has shown to present with psychosis in few cases. Psychotic symptoms result fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ca96ca77f18b5d8d04decbfb0b1381a
https://doi.org/10.4172/2572-0791.1000102
https://doi.org/10.4172/2572-0791.1000102
Publikováno v:
Drugs of the Future. 44:535
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f73d9f366710f08f9c3a0fc66468a94d
https://doi.org/10.1358/dof.2019.044.07.2962941
https://doi.org/10.1358/dof.2019.044.07.2962941